- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01357499
Lower Leg Remote Ischemic Preconditioning in Elective Percutaneous Coronary Intervention (PCI) (REMOTE)
Effects of Lower Leg Remote Ischemic Preconditioning in Combination With Electric Muscle Stimulation in Elective Coronary Artery Revascularisation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It has been demonstrated that protection from ischemia reperfusion can be achieved by brief periods of ischemia applied at a remote site during an injurious ischemic event (remote postconditioning). The purpose of this study is to investigate if the combination of brief periods of limb ischemia in combination with electric muscle stimulation at the same site could exceed the preconditioning effect of limb ischemia alone.
Therefore the investigators thought to perform 2 different forms of remote ischaemic preconditioning in patients undergoing elective coronary angioplasty.
In the first patient group a blood pressure cuff will be applied at the lower leg. Ischemia will be induced by inflating the cuff to a pressure of 200 mmHg for 5 minutes. Afterwards reperfusion will be allowed for further 5 minutes. This cycle will be repeated 3 times.
In a second patient group electric muscle stimulation at the same site (HiToP 191) will be performed additionally throughout the whole preconditioning cycle.
After preconditioning, the percutaneous coronary intervention (PCI) will be performed by 3 PCI-ballon inflations, each lasting for 2 minutes. Between the inflations coronary reperfusion will be allowed for 5 minutes.
The Effects of preconditioning will be evaluated by analysing the ST-deviation, caused by angioplasty in an intracoronary (derived by PCI wire) and surface ecg.
Also the maximum of chest pain during the 3 inflation cycles and troponin levels 24 h after PCI will be evaluated.
Study Type
Contacts and Locations
Study Locations
-
-
MVP
-
Greifswald, MVP, Germany, 17489
- Ernst Moritz Arndt Universität Greifswald
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- planned PCI of one of the main coronary artery (artery diameter distal of the stenotic area at least 2,5 mm)
- patient age 18 years or older
- stable angina pectoris symptoms
Exclusion Criteria:
- presence of collateral vessels
- electrocardiographic bundle branch blocks
- multiple coronary stenosis
- occlusion of a coronary artery
- renal insufficiency (GFR (MDRD) < 50 ml/min/1,73 m2)
- presence of coronary bypass grafts
- history or presence of myocardial infarction.
- echocardiographic signs of left ventricular hypertrophy (septal and/or posterior wall diameter greater than 14 mm)
- some sort of medications (adenosine, morphine and derivates, immunosuppressive agents, oral antibiotics, theophyllin, alpha receptor blockers)
- peripheral arterial disease
- exercise tests performed within 24 h before study start.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
control group
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg but without inflating the cuff and without stimulating the muscle.
Now 25 minutes will have to pass by before beginning the coronary angioplasty.
|
|
|
intervention group 1
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg.
The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
There will be no electrical muscle stimulation in this group.
|
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg.
The blood pressure cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
|
|
intervention group 2
A Blood pressure cuff and the muscle stimulator pads will be applied to one lower leg.
The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
In addition electrical muscle stimulation will be performed throughout the whole preconditioning cycle
|
A Blood pressure cuff and and the muscle stimulator pads will be applied to one lower leg.
The blood pressure Cuff will be inflated with 200 mmHg for 5 minutes.
Next reperfusion will be allowed for 5 minutes.
This cycle will be repeated for 3 times.
In addition electrical muscle stimulation will be performed throughout the whole preconditioning cycle.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ST deviation
Time Frame: 120 seconds after angioplasty
|
Immediately after the preconditioning cycle the PCI ballon will be positioned in the coronary artery lesion and inflated for 2 minutes followed by 5 minutes of reperfusion. This cycle will be repeated for 3 times without any interruption. Intracoronary ECGs and 12 lead surface ecgs will be taken immediately before and at the end of each ballon inflation (two minutes after beginning the intracoronary ballon inflation). after taking the ecgs the ballon will be deflated. The st-deviations will be analysed. |
120 seconds after angioplasty
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
troponin I
Time Frame: 24 hours after PCI
|
Troponin levels will be evaluated 24 h after PCI
|
24 hours after PCI
|
|
chest pain (Maximum)
Time Frame: time period 2 minutes
|
the maximal chest pain occuring during each of the Pci balloon inflations will be documented as a number out of 10. 0 is determined as no pain and 10 is determined as the heaviest pain which the patient ever experienced.
A specific timepoint has not been defined.
|
time period 2 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Markus Reinthaler, MD, Ernst Moritz Arndt University Greifswald
- Principal Investigator: Thorsten Reffelmann, MD, Ernst Moritz Arndt University Greifswald
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-reinthaler
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Heart Disease
-
Elumn8 MedicalEnrolling by invitationIschemic Heart Disease | Ischemic Heart Disease Chronic | Coronary Chronic Total Occlusions | Ischemic Heart Disease (IHD)United States
-
Genzyme, a Sanofi CompanyTerminatedIschemic Heart Disease | Ischemic Cardiomyopathy | Ischemic Heart FailureBelgium, France, Germany, Italy, Switzerland, United Kingdom
-
University of AlbertaActive, not recruitingCoronary Artery Disease | Stable Ischemic Heart Disease | Beta-blocker TherapyCanada
-
Yonsei UniversityRecruitingIschemic Heart Diease | Non-ischemic Heart DiseaseSouth Korea
-
Gerencia de Atención Primaria, MadridServicio Canario de Salud; Avedis Donabedian Research InstituteCompletedIschemic Heart Disease ChronicSpain
-
Michael SekelaCompletedChronic Ischemic Heart DiseaseUnited States
-
Cardiocentro TicinoTerminatedChronic Ischemic Heart DiseaseSwitzerland
-
Zoll Medical CorporationRecruitingCardiovascular Diseases | Cardiomyopathies | Heart Disease, Ischemic | Cardiomyopathy IschemicGermany
-
University of PecsCompleted
-
Rigshospitalet, DenmarkNot yet recruitingChronic Ischemic Heart DiseaseDenmark
Clinical Trials on blood pressure cuff
-
Mayo ClinicCompletedCoronary Artery IschemiaUnited States
-
Northwestern UniversityRecruitingHypertension | Obesity | Hypertension in PregnancyUnited States
-
University of AlbertaCompletedRemote Ischemic Preconditioning | Myocardial ProtectionCanada
-
St. Jude Children's Research HospitalCompleted
-
Xim LimitedBarts & The London NHS Trust; Mind Over Matter Medtech Ltd; Health Innovation...Recruiting
-
Johns Hopkins UniversityTerminatedAcute Myocardial InfarctionUnited States
-
Washington University School of MedicineThe Craig H. Neilsen FoundationRecruiting
-
Nemours Children's ClinicCompleted
-
University of New England, AustraliaTerminated
-
West Michigan Cancer CenterVeta HealthCompleted